2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Rose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case Control study.
Rose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case-Control Study.
In the study, which investigated risk factors in 4000 newly diagnosed patients with glioma, researchers sought to determine whether aspirin or non-steroidal anti-inflammatory agents (NSAIDs) were associated with a risk of disease. Earlier, smaller studies also looking at the association have demonstrated conflicting results, Lai says. However, recent evidence suggests that aspirin is associated with a lower risk of glioma.
Results of this study showed that aspirin was linked with a significant protective effect for patients with glioma; however, NSAIDs were only associated with reduced glioma risk in women.
<<<
Related Content: